Concepedia

Tammo Bialas

TB

Statistics

Publications

2

Citations

48

H-Index

2

Active since

1988

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Tammo Bialas is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, pharmacodynamics of immunotherapies, and chemotherapy drug administration.

Publications per year

1988–1988

2

Publications

2

Phase I trial of recombinant interleukin-2 and cyclophosphamide: augmentation of cellular immunity and T-cell mitogenic response with long-term administration of rIL-2.

Kolitz Je, Wong Gy, Karl Welte et al. · PubMed · 1988 · 35 citations

, , +15

Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.

Tammo Bialas, Jonathan E. Kolitz, Ester Levi et al. · PubMed · 1988 · 13 citations

, , +8

1–2 of 2